HOME >> BIOLOGY >> NEWS
Bigger betas are better Protein found to provide pancreatic cells with protection against diabetes

(Philadelphia, PA) While studying the proteins in pancreatic beta (β) cells the cells that produce insulin researchers at the University of Pennsylvania Medical Center discovered how the protein enzyme Akt1 can cause mice β cells to grow larger and produce more insulin. Their findings, published in this months Nature Medicine, have direct implications for the current need to increase the number of human pancreatic cells available for transplant to diabetic patients.

"The mice bred to produce excess Akt1 protein were more tolerant of glucose and more resistant to diabetes in fact, we simply could not give them diabetes when we tried," said Morris J. Birnbaum, MD, PhD, associate director of the Penn Diabetes Center in the Penn Departments of Medicine & Cell and Molecular Biology and an investigator in the Howard Hughes Medical Institute. "The increase in Akt1 directly leads to an increase in the size, amount, and total production of insulin by β cells."

In the United States, diabetes is the seventh leading cause of death and currently effects over 15 million people. Medical science recognizes two forms of diabetes. Type 1 diabetes results from the immune systems destruction of pancreatic β cells. Type 2 diabetes results when the body cannot either produce enough insulin or properly use the insulin it does produce. Without insulin, the body cannot utilize glucose blood sugar which can lead to a variety of debilitating illnesses, including heart disease, blindness, and kidney failure.

Recently, surgeons have met with success in treating the disorder by transplanting clusters of pancreatic cells, called islets, into diabetic patients. Transplanted islets, which include β cells, have been shown to reestablish the production of insulin in the pancreas. Unfortunately, the demand for islets far outweighs the supply.

"What makes our findings so interesting, clinically, is the potential to enlarge our pool of β cells f
'"/>

Contact: Greg Lester
lesterg@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine
18-Oct-2001


Page: 1 2

Related biology news :

1. Bigger isnt always better--especially if youre a rodent
2. Spray Forming Aerospace Alloys For Bigger Aircraft
3. New Sunspot Cycle To Be Bigger Than Average
4. Mapping The Way To A Bigger Prawn
5. Bigger Biology Tackled Through Keyboards
6. Lycopene slows human prostate tumour growth in mice and combined with vitamin E is even better
7. Microbes eat their way to better concrete
8. Computer database being developed at Temple will allow for better inventory of chemicals
9. New and better drugs for tuberculosis goal of UH professor
10. Ants protect plants better when jacked up on nectar
11. The blind really do hear better

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/19/2016)... TORONTO , 19 de diciembre de 2016  Mosaic Biomedicals ... el desarrollo acelerado de MSC-1, un anticuerpo humanizado que se espera ... en 2017, con múltiples sitios previstos a lo largo de Europa ... MSC-1 ... factor inhibidor de leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa ...
(Date:12/15/2016)... 15, 2016   WaferGen Bio-systems, Inc. (NASDAQ: ... company, announced today that on December 13, 2016, it ... The Nasdaq Stock Market LLC which acknowledged that, as ... WaferGen,s common stock had been at $1.00 or greater ... compliance with Listing Rule 5550(a)(2) of the Nasdaq Stock ...
(Date:12/12/2016)... 12, 2016  Researchers at Trinity College, Dublin, ... by combining the material with Silly Putty. The mixture ... detector able to sense pulse, blood pressure, respiration, ... The research team,s findings were ... here:  http://science.sciencemag.org/content/354/6317/1257 ...
Breaking Biology News(10 mins):
(Date:1/21/2017)... PARSIPPANY, N.J. , Jan. 20, 2017 /PRNewswire/ ... the "Company"), a company that provides clinically useful ... that it has entered into a securities purchase ... aggregate of 855,000 shares of common stock in ... placement, the Company has agreed to sell to ...
(Date:1/21/2017)... 20, 2017 Aratana Therapeutics, Inc. (NASDAQ: ... the licensing, development and commercialization of innovative biopharmaceutical products ... Company in North America 2016. ... based on the FDA approval of three innovative ... ® (capromorelin oral solution) and NOCITA ® ...
(Date:1/20/2017)... ... 2017 , ... The two newest companies to join the University City Science ... out from The Wistar Institute, and Sanguis, launched by a trio of students from ... , Vironika is developing a treatment for a chronic viral infection and its associated ...
(Date:1/20/2017)... 20, 2017 Ginkgo Bioworks, the organism ... pioneer in the synthesis and assembly of DNA. ... assembling pathway-length synthetic DNA into Ginkgo,s automated organism ... the construction of new organism designs for application ... "Gen9 was founded to significantly increase the world,s ...
Breaking Biology Technology:
Cached News: